Investor Ideas Adds New Stocks in #AI, #Cleantech, #Cannabis, Mining and Biotech ($NEWR, $NTNX $LOOP $PMD)

Investor Ideas Adds New Stocks in #AI, #Cleantech, #Cannabis, Mining and Biotech ($NEWR, $NTNX $LOOP $PMD)

Point Roberts, WA, Delta BC – February 22, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in AI, cleantech, cannabis, mining and biotech.

Investorideas.com is a go-to destination for retail investors and tracks companies in high-profile trading sectors and makes ongoing additions to its stock directories for its followers and members.

Read this in full at https://www.investorideas.com/news/2019/main/02221Stocks.asp

The newest tech companies are both involved in the use of AI in cloud computing and are listed on NYSE/Nasdaq markets.

The latest cleantech companies are involved in biodegradable/recyclable plastics and the lithium/EV sectors, respectively.

New in cannabis is the drug testing company, Psychemedics Corp. (NasdaqCM:PMD)which is the world’s largest provider of hair testing for the detection of drugs, including cannabis.

Finally this week, the latest companies added to mining and biotech are both listed on the CSE (Canadian Stock Exchange) and are operating within Canada.

New AI Companies:

New Relic (NYSE:NEWR) provides the real-time insights that software-driven businesses need to innovate faster. New Relic’s cloud platform makes every aspect of modern software and infrastructure observable, so companies can find and fix problems faster, build high-performing DevOps teams, and speed up transformation projects.  AI: New Relic Applied Intelligence (NRᴬᴵ) is a set of services that automatically finds meaning and solutions in your mountain of data. From advanced statistics to machine learning to artificial intelligence, NRᴬᴵ uses the right technique to give you answers to your most pressing issues—quickly and intelligently.

Nutanix (NASDAQGS:NTNX) is a global leader in cloud software and hyperconverged infrastructure solutions, making infrastructure invisible so that IT can focus on the applications and services that power their business. Companies around the world use Nutanix Enterprise Cloud OS software to bring one-click application management and mobility across public, private and distributed edge clouds so they can run any application at any scale with a dramatically lower total cost of ownership. The result is organizations that can rapidly deliver a high-performance IT environment on demand, giving application owners a true cloud-like experience. AI: Enterprise Cloud for AI

New Cleantech Companies:

Alternet Systems, Inc. (OTC: ALYI) is focused on offering varied, environmentally sustainable, energy storage solutions for targeted markets, including consumer electric vehicles and military applications. The first product category is lithium battery-powered motorcycles, to be followed by motorbikes. ALYI also recently brought Clarkson University Professor David Mitlin on board to lead a hemp energy storage initiative. Mitlin has successfully used hemp bast - the fiber left over from processing hemp - to construct carbon nanosheets that compete with, and in some respects, outperform the supercapacitor performance derived from more typical graphene nanosheets. Mitlin holds a US patent for his proprietary hemp energy storage technology.

Loop Industries, Inc. (NasdaqGM:LOOP) is a technology and licensing company whose mission is to accelerate the world’s shift toward sustainable plastic and away from our dependence on fossil fuels. Loop owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any colour, transparency or condition and even ocean plastics that have been degraded by the sun and salt, to its base building blocks (monomers).  The monomers are filtered, purified and repolymerized to create virgin-quality Loop™ branded PET plastic resin and polyester fiber suitable for use in food-grade packaging to be sold to consumer goods companies to help them meet their sustainability objectives.  Through our customers and production partners, Loop is leading a global movement toward a circular economy by raising awareness of the importance of preventing and recovering waste plastic from the environment to ensure plastic stays in the economy for a more sustainable future for all.

Cleantech and Climate Change Podcast

Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

New Cannabis Companies:

Psychemedics Corp. (NasdaqCM:PMD) is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods. Cannabis Testing

Learn more and sign up to hear other podcasts Or www.potcasts.ca

New Mining Companies:

Skarb Exploration Corp (CSE:SKARB)  is engaged in the business of mineral exploration in Canada with an objective to locate and develop economic mineral properties. Skarb Exploration Corp. holds the sole and exclusive right and option to acquire a 100% right, title, and interest in and to the RDR Gold Project located in Quebec, consisting of 16 mining claims.

New Biotech Companies:

Valeo Pharma Inc. (CSE:VPH)  is a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada. With a focus on neurodegenerative diseases, woman’s health, and oncology and supportive care, Valeo Pharma has a growing portfolio of innovative products and a platform to properly manage these products through all stages of commercialization. Headquartered in Kirkland, Quebec, Valeo Pharma has all capabilities internally to register and market health care solutions for Canadian patients.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com

800-665-0411

The Future Is Now; #BioelectronicMedicine Med Tech That’s Changing Lives: (NASDAQ: $BSGM) (NASDAQ: $NVTR) (NYSE: $BSX) (NASDAQ; $IRTC)

The Future Is Now; #BioelectronicMedicine Med Tech That’s Changing Lives: (NASDAQ: $BSGM) (NASDAQ: $NVTR) (NYSE: $BSX) (NASDAQ; $IRTC)

Point Roberts, WA, Delta, BC - February 21, 2019 - Investorideas.com, a leading investor news resource covering medical technology and healthcare stocks releases a snapshot looking at the rapid advancements happening in the med tech sector and how many of these “far off” projects are now on the verge of reality.

According to IDTechEx “The market for bioelectronic medicine will exceed $60 billion by 2029.” They explain Bioelectronic medicine, or electroceuticals, is the use of electrical stimulation to treat diseases of the human body in ways that current pharmaceutical interventions cannot.

BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, recently announced that the Company successfully conducted the first patient cases using PURE EP™ System, its FDA approved proprietary signal acquisition and processing technology. The first commercial use of the System was completed at the Texas Cardiac Arrhythmia Institute (“TCAI”) in Austin, TX.

Read this in full at https://www.investorideas.com/news/2019/biotech/02211Stocks-MedTech.asp

“With the use of the PURE EP™ System, I was able to identify cardiac signals which were previously undetectable to me. I believe that the PURE EP™ System could change diagnostic and treatment strategies of arrhythmias, leading to more successful outcomes,” commented Dr. Andrea Natale, who conducted the studies.

The PURE EP™ System was used during standard studies on patients with persistent atrial fibrillation and conducted in parallel with Abbott’s EnSite Precision™ and Biosense Webster’s (Johnson & Johnson) CARTO™ cardiac mapping systems. The goal of the first commercial use of the technology was aimed at validating the System’s key value proposition elements and report on the overall user experience during the procedure.

Kenneth L. Londoner, Chairman and CEO of BioSig Technologies stated, “We are well positioned to deliver on our strategic goals for 2019 and look forward to the expansion of our evaluation efforts in the coming months.”

The BioSig Technologies system will sell for $250,000 each, in addition to a $100,000 software license.

Nuvectra Corporation (NASDAQ: NVTR), a medical device company dedicated to neuromodulation, recently announced that the US Food and Drug Administration (FDA) has advised that its review of the Company’s pre-market approval (PMA) application for its Virtis Sacral Neuromodulation (SNM) system has been extended beyond the expiration of the FDA’s 180-day review period.

This small delay for the company will most likely be overshadowed by the release of its financial results for the fourth quarter and full year ended December 31, 2018 on Thursday, February 28, 2019 after market close.

Boston Scientific Corporation (NYSE: BSX) has reported their results for Q4 and the full year of 2018, in which they generated sales of $2.561 billion during Q4, representing growth of 6.3 percent on a reported basis, 8.2 percent on an operational basis and 7.0 percent on an organic basis, all compared to the prior year period.

For the full year 2018, the company generated sales of $9.823 billion, which represents growth of 8.6 percent on a reported basis, 8.0 percent on an operational basis and 7.2 percent on an organic basis, all compared to the prior year period.

Commenting on their earnings, Chairman and CEO Mike Mahoney said, "Meaningful innovation and focused execution helped us deliver strong financial results in 2018. We remain driven by the opportunity to help more patients with our life-changing technologies, including a robust long-term pipeline of new devices and therapies."

iRhythm Technologies, Inc. (NASDAQ: IRTC) technology combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Rhythm just reported financial results for the three months and full year ended December 31, 2018.

Companies with innovative products now being approved, tested, and brought to market are not only showing great financial growth for their shareholders but are also changing lives and adding new depths to the medical community. These innovations in medical technology are showing us that the future of healthcare is already here.

For investors following the sector; a directory of biotech and medical technology stocks.

About Investorideas.com

https://www.investorideas.com/About/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Social Media

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Get free news alerts

Disclaimer/Disclosure: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring BioSig Technologies is a paid for service on Investorideas.com (third party). Learn more about costs and our services https://www.investorideas.com/News-Upload/

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Investorideas.com - Walmart's (NYSE: $WMT) Influence in the #Healthcare Sector; Spreading Health and Wealth as Vendors Capitalize on Spending; (NYSE: $DGX) (OTC: $INND) (OTC: $RGBLY) (NYSE: $ANTM)

Investorideas.com - Walmart's (NYSE: $WMT) Influence in the #Healthcare Sector; Spreading Health and Wealth as Vendors Capitalize on Spending; (NYSE: $DGX) (OTC: $INND) (OTC: $RGBLY) (NYSE: $ANTM)

Walmart's (NYSE: $WMT) Influence in the #Healthcare Sector; Spreading Health and Wealth as Vendors Capitalize on Spending; (NYSE: $DGX) (OTC: $INND) (OTC: $RGBLY) (NYSE: $ANTM)

Point Roberts, WA and Delta, BC - February 13, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at increased quarterly sales for the sector thanks, in no small part, to Walmart (NYSE: WMT).

CNBC has reported on how Walmart is looking for ways to reduce health-care costs for its customers, and its employees. It's goal to take a leading role in healthcare is now spreading and is having an impact on the sector overall.

Multi-year deals with Walmart are impacting stocks in the sector, ranging from big companies like

CVS Health Corporation (NYSE: CVS)reporting in mid-January, "Walmart to Continue Participating in CVS Caremark Commercial and Managed Medicaid Retail Pharmacy Networks," to smaller vendors making inroads with the retail giant.

Directly benefiting from its relationship with Walmart, InnerScope Hearing Technologies Inc. (OTC:INND), a manufacturer and Direct-to-Consumer distributor/retailer of FDA-Registered Hearing Aids, announced yesterday that its quarterly sales rose 281% in the quarter ending December 31, 2018 and that this increase reflects the revenue compared to Q3.

"Today's announcement of our record-setting sales growth is in part from InnerScope's vendor relationship with Walmart.com and the development of multiple Direct-to-Consumer hearing aid sales channels, including the launching of several eCommerce DTC websites, as well as opening several corporate owned audiological hearing aid retail clinics," said Matthew Moore, CEO InnerScope Hearing Technologies. "Our national footprint has grown in the last quarter, in part by securing our manufacturing agreement with Zounds Hearing Inc. which played a major role for our record-setting sales by offering high quality patented hearing aids at 50% to 70% less than any of our competitors," continued Mr. Moore.

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services partnered with Walmart as early as 2017. The Company announced that it will report fourth quarter and full year 2018 results on Thursday, February 14, 2019, before the market opens.

Available in 48 states to consumers, Quest Diagnostics has long been a leader in the movement for consumer empowerment in healthcare. The company further expanded convenient access to testing services through its collaborations with Safeway and Walmart, and said they expected to have well over 200 patient service centers in retail store locations by the end of 2018.

Anthem, Inc., (NYSE: ANTM) one of the nation's leading health benefits companies is also in on the gains. The Anthem-Walmart program, launched in January 2019, enables consumers who are enrolled in Anthem's affiliated Medicare Advantage (MA) plans to use OTC plan allowances to purchase OTC medications and health-related items, such as first aid supplies, support braces, and pain relievers at Walmart's 4,700 stores and on Walmart.com.

Reckitt Benckiser Group LLC (OTC:RBGLY), a global leading consumer health and hygiene company also announced a partnership with Walmart on a groundbreaking campaign that aims to provide better healthcare access for consumers. Together, the companies have collaborated on a "telehealth" initiative with Doctor on Demand, the nation's leading virtual care provider, to make seeing doctors easier than ever before by easing the cost barrier and providing consumers with unprecedented access to high-quality, board-certified physicians on mobile phones, tablets or computers.

Another smaller vendor hoping to benefit from Walmart is Relevium Technologies Inc. (TSX.V:RLV) ( OTCQB:RLLVF). In December 2018, the company announced they had launched 30 new exclusive products under its Bioganix® Gold Brand in Walmart.com

Continued: On October 11, 2018, the Company announced it was targeting to launch 30 new products under its Bioganix® Gold Brand, which sell exclusively in Walmart.com. The Company has launched 14 out of the 30 new products and the balance is currently under the normal compliance review process and are expected to be live on Walmart.com and available to Walmart Shoppers over the next two weeks.

Walmart has given a great example of how large-scale retail companies can help reshape the healthcare landscape and this may lead other company giants like Amazon into the sector as well.

One thing these recent partnerships with Amazon have shown, is the mutual benefits that can come from such deals for the customer, employee and company financials. Also, as recently reported, Microsoft now has its sights set on battling Amazon in the lucrative health care market.

For the smaller vendors like InnerScope Hearing Technologies Inc. (OTC:INND), it's great news that the giants are all stepping in.

For investors following medical technology and healthcare stocks, Investor Ideas has created a directory of biotech and medical technology stocks

Get free news alerts

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Follow us on Social Media

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Get free news alerts

Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring InnerScope Hearing Technologies is a paid for service on Investorideas.com (third party). Learn more about costs and our services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Investorideas.com - Transforming #Healthcare with #DigitalHealth Technology : Innovest Global (OTC: $IVST), eWellness Healthcare (OTCQB: $EWLL), ResMed Inc. (NYSE: $RMD) and Progressive Care (OTCQB: $RXMD)

Investorideas.com - Transforming #Healthcare with #DigitalHealth Technology : Innovest Global (OTC: $IVST), eWellness Healthcare (OTCQB: $EWLL), ResMed Inc. (NYSE: $RMD) and Progressive Care (OTCQB: $RXMD)

Transforming #Healthcare with #DigitalHealth Technology : Innovest Global (OTC: $IVST), eWellness Healthcare (OTCQB: $EWLL), ResMed Inc. (NYSE: $RMD) and Progressive Care (OTCQB: $RXMD)

New York, NY, Delta BC - February 1, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how healthcare is changing in the digital age.

Investorideas recently reported on how Digital Health technologies enabling out-of-hospital care and monitoring are forecast to grow by 30 percent and cross the $25 billion mark.

In the article, Kamaljit Behera, Industry Analyst, Transformational Health said, "In this highly digitized environment, artificial intelligence (AI) will permeate the life sciences ecosystem, and its use in healthcare IT (HIT) is likely to cross $1.7 billion by the end of 2019. AI-powered IT tools that manage payers and providers business risks in clinical, operational, financial and regulatory settings will especially find high uptake. Blockchain in healthcare is slowly starting to migrate from pilot proof of concept (PoC) to early commercial implementations."

Innovest Global Inc. (OTC: IVST), a conglomerate with operations in commercial and industrial products and services, biotechnology, construction and building materials is one such company focused on the future of Digital Health. Innovest recently provided a recap of the company's solid performance, milestones and achievements in 2018 and their outlook for 2019.

The letter recaps the journey from a seven-employee company at the beginning of 2018 that generated $58,000 in revenue, to ending 2018 on a $40 million annual revenue run-rate with a conglomerate of operating businesses spanning various industries and 75 employees. Management expects at least 20% organic growth for 2019.

Daniel G. Martin, Founder, Chairman and CEO of Innovest commented, "We are the best-equipped company in biotech to help scientists and biotech companies achieve commercial success right now."

Martin continued, "Innovest Global's Biotech Division seeks to grow by targeting companies with innovative and transformative technologies in the Digital Health and Medical Device space. Nonetheless, we are also considering transformative technologies in stem cell biology and immunotherapy. Digital Health is one of the fastest growing markets in biotech. We seek to identify companies that have products in the market and are seeking accelerated and stable growth moving forward. More importantly, we want technology that will truly improve the quality of life for relatively healthy individuals and those that are struggling with debilitating conditions, including stroke, heart disease, brain injury and other disorders."

Companies like eWellness Healthcare Corporation (OTCQB:EWLL), a provider of the state of the art PHZIO platform for the physical therapy ("PT") and telehealth markets, recently announced the launch of a new body health assessment branded under the name "WellFit" that will operate on the company's PHZIO digital treatment platform.

The WellFit Exam is an online screening test designed to provide the participant with a comprehensive body health assessment. The results of the test will help guide the participant to areas which may need more focused efforts to allow them to engage in a more healthy and pain-free lifestyle. These online examinations will be performed in real-time by a licensed doctor of physical therapy. Physical therapists are uniquely qualified to assess and prescribe exercise-based interventions based around movement deficiency and dysfunction.

Digital Health companies like ResMed (NYSE:RMD) (ASX:RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, have been making acquisitions, such as their recent announcement regarding its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma.

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is a good indicator of the Digital Health market as the company reported a further growth year-over-year in revenue and number of prescriptions filled for December 2018.

In December, the company reported a total of $1.7 million in net revenue, a 6% increase from the same month last year, and a 45% increase in prescriptions filled during the same month last year, totaling nearly 28,332 prescriptions filled. This marks the strongest finish to the year in company history.

Companies like Innovest are fast becoming the rule, not the exception, as more companies begin to invest in the Digital Health market - the future of healthcare.

For investors following the sector,  Investor Ideas has created a directory of biotech and medical technology stocks

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI. 

Follow us on Social Media

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Get free news alerts

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring IVST is a paid for service on Investorideas.com . Learn more about costs and our services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks